Rx Update: February 2000
Mary Ross, R.Ph., M.B.A.
Peer Review Status: Internally Reviewed
|
__1. Alkeran® __2. Leukeran® __3. Myleran® __4. Sufenta® __5. Sublimaze® __6. Zyrtec® __7. Zyprexa® __8. Xenical® __9. Xeloda® __10. Avandia® __11.Prandin® |
a) chlorambucil is an alkylating chemotherapeutic agent b) cetirizine is a non-sedating antihistamine c) sufentanil is a narcotic analgesic d) melphalan is an alkylating chemotherapeutic agent e) rosiglitazone is a drug to treat type 2 diabetes f) busulfan is an alkylating chemotherapeutic agent g) capecitabine is a chemotherapeutic agent h) repaglinide is a drug to treat type 2 diabetes i) orlistat is indicated for management of obesity j) fentanyl is a narcotic analgesic k) olanzapine is an antipsychotic |
As manufacturers release new products, the similarity among names seems to increase. The likelihood of confusing similar sounding drugs is decreased when prescribers clearly print both brand and generic names. Synonyms and abbreviations should always be avoided. Adding the indication for use may also help to clarify the order. All health providers should ensure that the agents prescribed for patients conform to therapy consistent with the patient's diagnosis. Incorrect routes of administration or doses that seem relatively large or small as compared to commercially available strengths should also warrant investigation.